DiagnosTear Announces Frankfurt Stock Exchange Listing and Corporate Awareness Agreement

Executive Summary

• DiagnosTear Technologies Inc. (“DiagnosTear”) is now listed and trading on the Frankfurt Stock Exchange (FSE) under ticker “X8F.”
• The company has entered into a six‑month marketing services agreement with bullVestor Medien GmbH to promote its FSE listing and increase visibility among European investors.
• DiagnosTear will pay bullVestor a total fee of €300,000 (≈ $485,000) in installments; bullVestor holds no shares or securities of the company.

Key Details

• Listing: Common shares commenced trading on the Frankfurt Stock Exchange on October 21, 2025, ticker “X8F.”
• Purpose of Listing: Expand visibility, broaden European shareholder base, and improve liquidity for DiagnosTear’s stock.
• Marketing Services Agreement:
• Provider: bullVestor Medien GmbH (Austria).
• Term: 6 months starting October 21, 2025.
• Services include information distribution, media outreach, investor‑relations management, and other promotional activities targeting the German market.
• Fee: €300,000 total (≈ $485,000), payable in installments.
• Share Ownership: bullVestor and its principals do not own any DiagnosTear common shares or securities at the time of agreement execution.
• CEO Quote: “Listing on the Frankfurt Stock Exchange represents a significant milestone for DiagnosTear as we expand our presence in the European capital markets.” – Shimon Gross, CEO.

Notable Quotes

"We are committed to fostering strong relationships with European investors and believe this listing will help us achieve greater visibility and liquidity across the region." – Shimon Gross, CEO, DiagnosTear Technologies Inc.